"Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"

NCT05874505 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Behcet's Uveitis

Interventions

DRUG: Adalimumab
DRUG: Tocilizumab

Sponsor

Assistance Publique - Hôpitaux de Paris